Red Blood Cell Eicosapentaenoic Acid Inversely Relates to MRI-Assessed Carotid Plaque Lipid Core Burden in Elders at High Cardiovascular Risk.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28930197)

Published in Nutrients on September 20, 2017

Authors

Núria Bargalló1,2, Rosa Gilabert3, Edwin-Saúl Romero-Mamani4, Montserrat Cofán5,6, Philip C Calder7,8, Montserrat Fitó9,10, Dolores Corella11,12, Jordi Salas-Salvadó13, Miguel Ruiz-Canela14,15, Ramon Estruch16,17, Emilio Ros18,19, Aleix Sala-Vila20,21

Author Affiliations

1: Radiology Department, Clinical Diagnostic Imaging Centre, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain; bargalloclinic.ub.es (N.B.). gilabert@clinic.ub.es.
2: Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August i Sunyer, 08036 Barcelona, Spain. gilabert@clinic.ub.es.
3: Radiology Department, Clinical Diagnostic Imaging Centre, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain; bargalloclinic.ub.es (N.B.).
4: Department of Internal Medicine, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain. eromero@hotmail.com.
5: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. mcofan@clinic.cat.
6: Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain. mcofan@clinic.cat.
7: Human Development and Health Academic Unit, University of Southampton, Southampton SO16 6YD, UK. P.C.Calder@soton.ac.uk.
8: NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Fundation Trust, Southampton SO16 6YD, UK. P.C.Calder@soton.ac.uk.
9: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. mfito@imim.es.
10: Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona Biomedical Research Park, 08003 Barcelona, Spain. mfito@imim.es.
11: Ciber Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
12: Department of Epidemiology and Department of Biochemistry and Molecular Biology, School of Medicine, Valencia University, Valencia, Spain.
13: Ciber Fisiopatología Obesidad y Nutrición (CIBEROBN, CB06/03), Instituto de Salud Carlos III, Edificio D 1 º Planta, Hospital Clínico Universitario de Santiago de Compostela Choupana s/n, 15706 Santiago de Compostela, Spain ; Human Nutrition Department, School of Medicine, University Rovira i Virgili, Sant Llorenc 21, Reus, 43201 Tarragona, Spain.
14: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. mcanela@unav.es.
15: Department of Preventive Medicine and Public Health, University of Navarra, 31080 Pamplona, Spain. mcanela@unav.es.
16: Department of Internal Medicine, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain. restruch@clinic.cat.
17: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. restruch@clinic.cat.
18: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. eros@clinic.ub.es.
19: Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain. eros@clinic.ub.es.
20: Ciber Fisiopatología de la Obesidad y Nutrición , Instituto de Salud Carlos III, 28039 Madrid, Spain. asala@clinic.ub.es.
21: Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August i Sunyer, Hospital Clínic, 08036 Barcelona, Spain. asala@clinic.ub.es.

Articles cited by this

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 26.76

Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr (1997) 11.07

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56

Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res (2008) 4.88

Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ (2014) 3.56

Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol (2004) 3.37

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis (2010) 2.65

Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr (2010) 2.22

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J (2016) 2.09

Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol (2010) 1.89

[Analysis of trends in myocardial infarction case-fatality, incidence and mortality rates in Girona, Spain, 1990-1999]. Rev Esp Cardiol (2007) 1.57

The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res (2012) 1.40

Biological variability of blood omega-3 biomarkers. Clin Biochem (2009) 1.31

The omega-3 index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep (2009) 1.19

Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol (2008) 1.06

Omega-3 fatty acid blood levels: clinical significance and controversy. Circulation (2013) 1.06

Multislice dark-blood carotid artery wall imaging: a 1.5 T and 3.0 T comparison. J Magn Reson Imaging (2006) 1.01

Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br J Nutr (2011) 1.01

Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol (1999) 0.95

Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study. BMJ (2003) 0.90

Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2006) 0.88

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis (2015) 0.86

Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis. Biochim Biophys Acta (2014) 0.81

Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res (2016) 0.81

Non-invasive vulnerable plaque imaging: how do we know that treatment works? Eur Heart J Cardiovasc Imaging (2014) 0.80

Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin. Atherosclerosis (2016) 0.79

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes. Biochim Biophys Acta (2016) 0.78

Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation (2017) 0.77